Seguro Surgical Acquires Worldwide Rights to Johns Hopkins University Abdominal Surgery Device

COLUMBIA, Md., Oct. 19 /PRNewswire/ -- Seguro Surgical, Inc., a medical device development company specializing in the commercialization of surgical instrumentation, today announced that it has acquired, from The Johns Hopkins University, the global marketing rights to a novel device for use in abdominal surgery.

Over two million abdominal surgeries (laparotomies) are performed annually in the United States. Current practice utilizes cotton towels or sponges to reposition the bowel and allow access to the surgical area. This procedure is time consuming, presents potential safety risks to patients and can lead to post-operative complications. Seguro's "Lap-Pak" device is a flexible, one-piece, device contoured to enable the rapid and secure re-positioning of the bowels to expose the surgical site.

The device was developed by surgeons and biomedical engineering students from the BME undergraduate design course at Johns Hopkins under the leadership of Robert E. Bristow, M.D., M.B.A., Professor, Director, Kelly Gynecological Oncology Service and Director, Johns Hopkins Ovarian Cancer Center of Excellence.

Dr. Steve Kubisen, President and Chief Executive Officer of Seguro, stated, "We believe that this elegantly simple device will improve the overall efficiency of laparotomies and generate substantial reductions in overall healthcare costs. We are very excited to be working with Johns Hopkins and hope that this will be the first of many collaborative ventures that we undertake together."

Seguro is a portfolio company of FirstStage Bioventures LLC, an investment company which creates value through the licensing, development and ultimate sale of early stage medical technologies. For more information see the company's website at www.segurosurgical.com.